DITFX | RFITX | DITFX / RFITX | |
Total Expense Ratio | 0.37 | 0.37 | 100% |
Annual Report Gross Expense Ratio | 0.37 | 0.37 | 100% |
Fund Existence | 8 years | 16 years | - |
Gain YTD | 11.346 | 11.340 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 37.8B | 37.8B | 100% |
Annual Yield % from dividends | 1.22 | 1.21 | 100% |
Returns for 1 year | 13.58 | 13.56 | 100% |
Returns for 3 years | 42.99 | 43.05 | 100% |
Returns for 5 years | 49.14 | 49.18 | 100% |
Returns for 10 years | N/A | 85.25 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
QIS | 22.62 | 0.41 | +1.85% |
Simplify Multi-QIS Alternative ETF | |||
VFMF | 137.29 | 1.09 | +0.80% |
Vanguard US Multifactor ETF | |||
ESML | 42.52 | 0.32 | +0.76% |
iShares ESG Aware MSCI USA Small-Cap ETF | |||
FTXH | 26.31 | N/A | +0.01% |
First Trust Nasdaq Pharmaceuticals ETF | |||
FMCE | 26.35 | N/A | N/A |
FM Compounders Equity ETF |